• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

August 22, 2017

Trending News Today: Ovarian Cancer Patient Awarded $417 Million in J&J Baby Powder Lawsuit

Author(s):

Lauren Santye, Assistant Editor

Top news of the day from across the health care landscape.

A woman diagnosed with ovarian cancer in 2007 was awarded $417 million in a lawsuit against Johnson & Johnson talcum powder. According to USA Today, the verdict was reached by a Los Angeles jury in the case, in which plaintiff Eva Echeverria alleged J&J was aware of the potential dangers from using talcum-based products for personal hygiene but refused to warn the public. Echeverria used Johnson Baby Powder—–sometimes twice per day––for 41 years and continued even after being diagnosed with ovarian cancer, according to the article. It was only after a news report in February 2016 of a woman who filed a lawsuit alleging she became ill from the same talcum-based product that Echeverria stopped using the powder. J&J spokeswoman Carol Goodrich said in a statement reported by USA Today, “ovarian cancer is a devastating diagnosis and we deeply sympathize with the women and families impacted by this disease. We will appeal today’s verdict because we are guided by the science, which supports the safety of Johnson’s Baby Powder.” Ovarian cancer is the fifth leading cause of cancer deaths among women, accounting for more deaths than any other cancer of the female reproductive system, according to the American Cancer Society.

New findings suggest marijuana may be linked to hypertension, according to The New York Times. The investigators analyzed data from a large health study that included 1213 individuals. Among the participants, 332 deaths occurred, of whom 57% were marijuana users. Even after adjusting for health and behavioral variables, including a prior hypertension diagnosis, the findings showed marijuana users had more than 3 times the risk of death from hypertension-related causes compared with nonusers, according to the article. Although a link to cardiovascular disease and stroke caused by hypertension was observed, it was not statistically significant. “There is a possibility that marijuana use is related to deaths with hypertension as an underlying cause,” lead author Barbara A. Yankey told the NY Times. “People who use marijuana should have regular medical checkups to assess their cardiovascular health.” The authors added that caution should be taken in interpreting this exploratory study.

Americans flooded the streets yesterday to watch the solar eclipse. In a new interview, optometry expert Ralph Chou spoke with NPR to discuss the potential aftermath on the eyes. Symptoms of a damaged retina take at least 12 hours before emerging and include blurred vision, with the center of the vision containing a spot or multiple spots, according to Chou. This type of vision loss can get better over several months to a year depending on the extent of damage, but approximately half of the time it is permanent. If individuals only saw the sun for a fraction of a second without a protective filter, the chances of damaging their eyes is very low. Those who looked at the display of a camera or smartphone, but did not look through the optics at the sun, are not in danger.

Related Videos
Menoapuse spelled with wooden blocks -- Image credit: loran4a | stock.adobe.com
Related Content
Advertisement
Woman can't eat bread and grain products because of gluten intolerance. A young celiac woman suffers from abdominal pain after eating fresh bread - Image credit: weyo | stock.adobe.com
May 30th 2025

FDA Grants Fast Track Designation to Drug Candidate for Celiac Disease

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Liver with fibrosis -- Image credit: Rasi | stock.adobe.com
May 30th 2025

Elecsys PRO-C3 Test Aims to Improve Precision Evaluation of Liver Fibrosis Severity

Gillian McGovern, Associate Editor
Pharmacy Focus: World Psychedelics Day
June 14th 2024

Pharmacy Focus: World Psychedelics Day

Ashley Gallagher, Editor
Prague, Czech Republic - August 28 2024: STELARA box with USTEKINUMAB active substance by JANSSEN, used for psoriasis, Crohn’s disease, and ulcerative colitis.
May 28th 2025

FDA Approves Ustekinumab-hmny Injection, a Biosimilar Referencing Stelara

Luke Halpern, Assistant Editor
Pharmacist working with gene therapy -- Image credit: RFBSIP | stock.adobe.com
May 28th 2025

The Intersection of Pharmacists and Biotechnology: Advancements and Challenges

Nicole Aldover, PharmD, RPh Satyaharshini Reddy, PharmD Zahra Arsalan, PharmD, RPh Sawyer Patrick, PharmD, RPh
Related Content
Advertisement
Woman can't eat bread and grain products because of gluten intolerance. A young celiac woman suffers from abdominal pain after eating fresh bread - Image credit: weyo | stock.adobe.com
May 30th 2025

FDA Grants Fast Track Designation to Drug Candidate for Celiac Disease

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Liver with fibrosis -- Image credit: Rasi | stock.adobe.com
May 30th 2025

Elecsys PRO-C3 Test Aims to Improve Precision Evaluation of Liver Fibrosis Severity

Gillian McGovern, Associate Editor
Pharmacy Focus: World Psychedelics Day
June 14th 2024

Pharmacy Focus: World Psychedelics Day

Ashley Gallagher, Editor
Prague, Czech Republic - August 28 2024: STELARA box with USTEKINUMAB active substance by JANSSEN, used for psoriasis, Crohn’s disease, and ulcerative colitis.
May 28th 2025

FDA Approves Ustekinumab-hmny Injection, a Biosimilar Referencing Stelara

Luke Halpern, Assistant Editor
Pharmacist working with gene therapy -- Image credit: RFBSIP | stock.adobe.com
May 28th 2025

The Intersection of Pharmacists and Biotechnology: Advancements and Challenges

Nicole Aldover, PharmD, RPh Satyaharshini Reddy, PharmD Zahra Arsalan, PharmD, RPh Sawyer Patrick, PharmD, RPh
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Download on Apple
© 2025 MJH Life Sciences

All rights reserved.